Cohen Yuval

Chief Executive Officer

1 company

Strong

Trades Analyzed

12M Win Rate

71.4%

Avg 3M Return

-3.0%

Avg 12M Return

+25.3%

Cohen Yuval is a Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.. Recent SEC Form 4 filings include 7 buys and 11 sells.

Estimated insider holdings value: $2.1M based on current market prices.

Holdings by Company

CRBPJan 14, 2026

Current Shares188.2K

Value$2.06M

Net Activity-42,825

Bought: 55.3KSold: 98.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 27, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Sale+OE	27,633	$17.05	$471,203.82	-9.1%	-45.1%	-
Feb 14, 2025	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Sell	7,134	$8.76	$62,464.59	-4.9%	-15.3%	-11.2%
Jun 18, 2024	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Sale+OE	63,358	$46.57	$2,950,518.18	-8.7%	+23.0%	-81.0%
Aug 10, 2022	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	3,800	$0.26	$1,003.20	+4.0%	-49.8%	-16.6%
May 16, 2022	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	10,500	$0.25	$2,625.00	+12.5%	-13.7%	+16.8%
Mar 9, 2022	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	8,600	$0.37	$3,182.00	+11.4%	-23.3%	-78.6%
Nov 11, 2020	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	4,240	$1.21	$5,126.16	+6.0%	-	-
Mar 17, 2020	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	4,300	$3.49	$15,007.00	+6.4%	-	-
Nov 12, 2019	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,430	$4.26	$6,091.80	+2.2%	-	-
Aug 12, 2019	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,175	$6.06	$7,115.80	+1.8%	-	-